On the morning of July 13, Jin Zhenhui, deputy director of the Department of device supervision of the State Drug Administration, Xu Song, first-class chief staff member of the first supervision division, Ma Gong of the second supervision division, Wei Lan of the audit and inspection center, and a delegation attended the meeting of Xu Fuxin, deputy director of the provincial drug administration, Wang Ping, director of the Department of device production supervision and management, and Yang Kai, director of the Department of device production supervision, Accompanied by Yin Xiaojian, director of the fifth branch of the provincial food and drug administration, Zhou Ji'an, vice mayor of Tianchang City, Wu Wenqiang, director of Tianchang City market supervision and Administration Bureau, and Cao Guangming, deputy director of Tiankang medical technology and Tiankang hospital, Anhui Province, the investigation and supervision work was carried out. Zhao Kuan, chairman of Anhui Tiankang group, Mao Wenwen, general manager, and Bai Baodong, deputy general manager warmly received the investigation and inspection team.
During the investigation and inspection forum, Jin Zhenhui pointed out that the supervision and inspection of medical devices for epidemic prevention and control organized by the State Drug Administration is, on the one hand, to understand the actual operation of medical device manufacturers, on the other hand, to help enterprises find and solve problems in daily system operation, and make real-time improvement; Medical device manufacturers should attach great importance to product quality management, especially in such a background of anti epidemic, to ensure the quality and safety of epidemic prevention and control medical device products is not only a problem of the healthy operation of the enterprise system, but also a social responsibility. Tiankang group should make full use of the advantages of Tiankang hospital, Tiankang pharmaceutical and Tiankang medical in the big health industry, concentrate efforts, broaden channels, make contributions to epidemic prevention and anti epidemic, and make contributions to human life and health.
Xu Fuxin, deputy director of the provincial drug administration, said in the forum that the provincial drug administration will implement the supervision requirements of the State Administration, work with enterprises to ensure the quality and safety of epidemic prevention and control medical devices, help enterprises to do a good job in product quality supervision, and help Tiankang group promote the comprehensive development of the big health industry.
Zhao Kuan, chairman of the group, said that while promoting the high-quality development of the enterprise, Anhui Tiankang group has always carried forward the spirit of dedication, shouldered the social responsibility, made every effort to help the epidemic prevention and control work, comprehensively developed the big health industry, and took "the health of the world and the pursuit of Tiankang people" as its own responsibility, continuously innovated, researched and developed new products, and served human health. It is believed that with the keen care and strong support of the State Bureau, Provincial Bureau and Municipal Bureau, Tiankang group will further improve and strengthen the big health industry and make due contributions to human life and health.
At the meeting, Bo Baodong, deputy general manager of the group, made a detailed report on the production, operation and products of Tiankang medical technology company. During the meeting, the structure and performance of the products were displayed and the factory was visited.